Judges Scientific (GB:JDG) has released an update.
Judges Scientific PLC reported a marginal revenue decline and a 16% drop in adjusted pre-tax profit in its H1 2024 interim results, amidst challenging market conditions and a subdued organic trading performance. Despite these headwinds, the company completed three acquisitions, strengthened its executive team, and increased its interim dividend by 10%, signaling resilience and a commitment to long-term shareholder value. The company expects a stronger second half, with some recovery in order intake and no changes to the full-year guidance.
For further insights into GB:JDG stock, check out TipRanks’ Stock Analysis page.
